The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of tumorigenesis, the TIME ...

Every winter, influenza returns with a new variant. People who have previously been infected with or vaccinated against flu ...

Johnson & Johnson announces Carvykti demonstrated significantly higher rates of MRD negativity compared to standard therapies in CARTITUDE-4 study: San Diego Wednesday, December 1 ...

The new understanding of molecular events that drive the various forms of amyloidosis has generated treatment strategies that ...

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced the selection of 10 abstracts for poster presentations and two abstracts for online publication at ...

Questioning whether the Corporate Transparency Act is dead, giving at the office, year-end tax strategies, tax deadlines and ...

Learn who can donate blood to you and who you can donate to, plus the importance of blood types, Rh factors, and why ...

Researchers have shown how genetic defects in Toxoplasma gondii are rescued if co-infected with normal parasites, thanks to ...

The fight against cancer involves new personalized treatments increasingly based on the analysis of the spectrum of mutations ...

Researchers identified a new receptor, neuropilin-1 (NRP1), which collaborates with a known receptor to regulate pain ...

By illuminating how diet and other lifestyle factors may affect a person's likelihood of developing a blood disorder as well as disease progression and response to treatment, the studies point to ...

Neflamapimod did not demonstrate statistically significant effects versus placebo on primary and secondary endpoints at 16 weeks——Favorable ...